Skip to content
Search

Latest Stories

UK records lowest increase in Covid-19 death toll since March

The number of people who have died in the United Kingdom after testing positive for Covid-19 rose by 170 to 34,636, business minister Alok Sharma said on Sunday (17), the lowest increase in the official death toll since March 24.

The increase reported on Sunday was sharply down from the 468 rise in deaths reported 24 hours earlier and the lowest since Britain brought in a lockdown to curb the spread of the virus on March 23.


However, at weekends the number of recorded deaths has been lower than the number reported during the week, and health officials in England also said its Covid Patient Notification System had not operated for a while on Saturday (16).

"The consequences of this situation may therefore be reflected in the number of deaths reported today," NHS England said.

The rise in the number of deaths in Britain from the virus peaked at 1,172 on April 21 according to official data and has been falling steadily since then. Other government statistics which include deaths due to suspected cases indicate that Britain's toll is over 40,000.

Sharma said 243,303 people in Britain had so far tested positive for the virus, an increase of 3,142 since Saturday.

Sharma also said that Oxford University and drug maker AstraZeneca had struck a global licensing deal for a vaccine that Oxford scientists were working on, one of the front runners in the global race to provide protection against the new coronavirus causing the Covid-19 pandemic.

If the vaccine proves successful, AstraZeneca will mass produce 100 million doses with up to 30 million doses available for people in the UK by September.

"The UK will be first to get access," Sharma said, adding that the government was providing an additional £84 million ($101.67m) in funding to British researchers working on potential vaccines.

(Reuters)

More For You

GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less